TRAX on Nasdaq

First Tracks Biotherapeutics, Inc.

American pharmaceutical preparations company based in San Diego.

Price unavailable

Last updated Oct 18, 2026.

Overview

Compare with another stock.

  • TickerTRAX on Nasdaq
  • IndustryPharmaceutical Preparations
  • HeadquartersSan Diego, United States
  • Incorporated inDE2
  • Business address10770 Wateridge Circle, Suite 210, San Diego, Ca 921212
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Leadership

Who has led First Tracks Biotherapeutics, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Daniel Faga2026–now

President

  1. Daniel Faga2026–now

Chief financial officer

  1. Ajim Tamboli2026–now
Board members and other officers (9)

Former names

  • Biopharma Company, Inc.Feb 6, 2026 to Feb 6, 20262

Timeline

  1. Apr 1, 2026New chief executive Daniel Faga becomes CEO3
  2. Oct 17, 2025Founded First Tracks Biotherapeutics, Inc. is founded13

Filings

86 filings to the SEC since October 2021: 2 quarterly reports, 7 major events, 56 insider forms, 6 large holders, 15 other. The latest 20:

  1. Oct 15, 20268-K EDGAR
  2. Oct 13, 20268-K EDGAR
  3. Sep 17, 20264 EDGAR
  4. Sep 4, 20264 EDGAR
  5. Sep 2, 2026144 EDGAR
  6. Aug 18, 20264 EDGAR
  7. Aug 18, 20264 EDGAR
  8. Aug 18, 20264 EDGAR
  9. Aug 14, 2026SCHEDULE 13G EDGAR
  10. Aug 14, 2026SCHEDULE 13G EDGAR
  11. Aug 13, 2026424B3 EDGAR
  12. Aug 13, 2026SCHEDULE 13G EDGAR
  13. Aug 12, 202610-Q EDGAR
  14. Aug 12, 20268-K EDGAR
  15. Aug 7, 20263/A EDGAR
  16. Aug 7, 20263/A EDGAR
  17. Aug 7, 20263/A EDGAR
  18. Aug 6, 2026SCHEDULE 13G EDGAR
  19. Aug 5, 20264 EDGAR
  20. Aug 5, 20264 EDGAR

The 86 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 6 such filings since October 2021:

  1. Aug 14, 2026SCHEDULE 13G
  2. Aug 14, 2026SCHEDULE 13G
  3. Aug 13, 2026SCHEDULE 13G
  4. Aug 6, 2026SCHEDULE 13G
  5. Jul 28, 2026SCHEDULE 13G
  6. Apr 22, 2026SCHEDULE 13G

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
EcoR1 Capital, LLC3,174,519$63.9M3.2%New
TCG Crossover Management, LLC2,895,304$58.3M1.4%New
Fmr LLC2,054,127$41.3M0.0%New
Affinity Asset Advisors, LLC2,032,012$40.9M2.0%New
BlackRock, Inc.1,963,541$39.5M0.0%New
Trails Edge Capital Partners, LP1,514,000$30.5M4.8%New
Vanguard Capital Management LLC1,451,909$29.2M0.0%New
Jupiter Topco LLC1,091,464$22.0M0.0%New
Vestal Point Capital, LP1,013,000$20.4M0.5%New
Woodline Partners LP917,176$18.5M0.1%New
Sanofi821,917$16.5M3.1%New
Morgan Stanley781,534$15.7M0.0%New
683 Capital Management, LLC750,000$15.1M1.4%New
Adage Capital Partners Gp, L.l.c.729,000$14.7M0.0%New
Balyasny Asset Management L.P.714,948$14.4M0.0%New
Geode Capital Management, LLC702,087$14.1M0.0%New
Bank Of America Corp /de/647,962$13.0M0.0%New
Stempoint Capital LP622,723$12.5M2.2%New
Palo Alto Investors LP603,489$12.1M1.7%New
Sofinnova Investments, Inc.565,199$11.4M0.6%New
Vanguard Portfolio Management LLC546,992$11.0M0.0%New
Nantahala Capital Management, LLC500,000$10.1M0.3%New
Goldman Sachs Group Inc487,213$9.8M0.0%New
Point72 Asset Management, L.P.408,330$8.2M0.0%New
UBS Group AG310,886$6.3M0.0%New

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13